More than 13,500 bottles of chlorthalidone tablets are being recalled nationwide because the medication may not dissolve properly, potentially reducing the dose absorbed by patients.
The recall involves 25-milligram tablets from Inventia Healthcare. The affected bottles have batch number RISA24002 and expire in March 2027.
The FDA has classified the recall as Class II, meaning the medication could cause temporary or medically reversible health problems.
